Beyond Air, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
XAIR Nasdaq 2830 www.beyondair.net

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Beyond Air, Inc.

Here's Why Beyond Air (XAIR) Could be Great Choice for a Bottom Fisher - Jun 26th, 2025 7:55 am
Beyond Air Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag - Jun 19th, 2025 12:24 pm
Beyond Air Inc (XAIR) (Q4 2025) Earnings Call Highlights: Revenue Soars Amidst Strategic Global ... - Jun 18th, 2025 1:01 am
Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Jun 17th, 2025 2:01 pm
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH - Jun 16th, 2025 6:00 am
Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast - May 20th, 2025 6:00 am
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO) - Apr 24th, 2025 2:05 pm
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism - Apr 21st, 2025 2:05 pm
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board - Apr 15th, 2025 2:05 pm
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home - Apr 9th, 2025 2:05 pm
NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders - Apr 1st, 2025 6:00 am
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site - Mar 31st, 2025 6:00 am
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy - Mar 24th, 2025 2:05 pm
Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH - Mar 11th, 2025 5:30 am
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences - Mar 6th, 2025 2:05 pm
Beyond Air Third Quarter 2025 Earnings: Beats Expectations - Feb 12th, 2025 3:51 am
Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update - Feb 10th, 2025 2:05 pm
Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - Feb 5th, 2025 7:29 am
Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast - Jan 27th, 2025 2:05 pm
Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia - Jan 24th, 2025 7:15 am